Literature DB >> 1326814

Sequences within the feline immunodeficiency virus long terminal repeat that regulate gene expression and respond to activation by feline herpesvirus type 1.

Y Kawaguchi1, J Norimine, T Miyazawa, C Kai, T Mikami.   

Abstract

We constructed a series of deletion mutants of feline immunodeficiency virus (FIV) long terminal repeat (LTR) to identify the regions that regulate gene expression and are responsive to trans-activation of FIV LTR by feline herpes-virus type 1 (FHV-1). We demonstrated that sequences between -124 and -79, and between -21 and -32 (relative to the cap site) are essential for gene expression of FIV in Felis catus whole fetus 4 (fcwf-4) cells. Further, we demonstrated that the sequence between -63 and -23 responds to trans-activation of FIV LTR by FHV-1 in fcwf-4 cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1326814     DOI: 10.1016/0042-6822(92)91235-m

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  Dual-emission fluorescence resonance energy transfer (FRET) real-time PCR differentiates feline immunodeficiency virus subtypes and discriminates infected from vaccinated cats.

Authors:  Chengming Wang; Calvin M Johnson; Sudhir K Ahluwalia; Erfan Chowdhury; Yihang Li; Dongya Gao; Anil Poudel; K Shamsur Rahman; Bernhard Kaltenboeck
Journal:  J Clin Microbiol       Date:  2010-03-24       Impact factor: 5.948

2.  Roles of the auxiliary genes and AP-1 binding site in the long terminal repeat of feline immunodeficiency virus in the early stage of infection in cats.

Authors:  Y Inoshima; M Kohmoto; Y Ikeda; H Yamada; Y Kawaguchi; K Tomonaga; T Miyazawa; C Kai; T Umemura; T Mikami
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

Review 3.  Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

Authors:  M Bendinelli; M Pistello; S Lombardi; A Poli; C Garzelli; D Matteucci; L Ceccherini-Nelli; G Malvaldi; F Tozzini
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

4.  Demonstration that orf2 encodes the feline immunodeficiency virus transactivating (Tat) protein and characterization of a unique gene product with partial rev activity.

Authors:  A de Parseval; J H Elder
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

Review 5.  The genome of feline immunodeficiency virus.

Authors:  T Miyazawa; K Tomonaga; Y Kawaguchi; T Mikami
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

6.  Effects of insertion of multiple AP-1 binding sites into the U3 region of the long terminal repeat of feline immunodeficiency virus.

Authors:  T Miyazawa; K Tomonaga; Y Kawaguchi; M Kohmoto; Y Inoshima; K Maeda; T Mikami; K ] Maedadel K [corrected to Maeda
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

7.  Effect of type-I interferon on retroviruses.

Authors:  Esperanza Gómez-Lucía; Victorio M Collado; Guadalupe Miró; Ana Doménech
Journal:  Viruses       Date:  2009-10-27       Impact factor: 5.048

Review 8.  The molecular biology of feline immunodeficiency virus (FIV).

Authors:  Julia C Kenyon; Andrew M L Lever
Journal:  Viruses       Date:  2011-11-09       Impact factor: 5.048

9.  First Molecular Characterization of Feline Immunodeficiency Virus in Domestic Cats from Mainland China.

Authors:  Jilei Zhang; Liang Wang; Jing Li; Patrick Kelly; Stuart Price; Chengming Wang
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

Review 10.  Haematological disorders associated with feline retrovirus infections.

Authors:  M L Linenberger; J L Abkowitz
Journal:  Baillieres Clin Haematol       Date:  1995-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.